Magnetar Financial’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
VCM
VPM
Magnetar Financial's CRL Position: Q1 2026 in Review
Magnetar Financial sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 4,804 shares — an estimated $958K sold.
Magnetar Financial first reported a position in CRL in Q2 2015 and held it in 13 quarters. The position peaked at $20M in Q4 2019. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- Magnetar Financial reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
- Magnetar Financial sold 4,804 Charles River Laboratories shares in Q1 2026, an estimated $958K.
- Magnetar Financial first reported a position in Charles River Laboratories in Q2 2015 and held it in 13 quarters.
- Magnetar Financial's Charles River Laboratories position peaked at $20M in Q4 2019.
- 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on Magnetar Financial's 13F filing for Q1 2026, filed 13 May 2026.